A detailed history of Klcm Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Klcm Advisors, Inc. holds 13,351 shares of MRK stock, worth $1.31 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
13,351
Previous 13,064 2.2%
Holding current value
$1.31 Million
Previous $1.62 Million 6.25%
% of portfolio
0.18%
Previous 0.2%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$111.15 - $128.97 $31,900 - $37,014
287 Added 2.2%
13,351 $1.52 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $25,502 - $27,389
206 Added 1.6%
13,064 $1.62 Million
Q1 2024

May 16, 2024

BUY
$113.24 - $131.95 $7,926 - $9,236
70 Added 0.55%
12,858 $1.7 Million
Q4 2023

Jan 30, 2024

SELL
$100.18 - $109.02 $4,007 - $4,360
-40 Reduced 0.31%
12,788 $1.39 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $13,692 - $15,205
133 Added 1.05%
12,828 $1.32 Million
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $30,302 - $33,028
279 Added 2.25%
12,695 $1.46 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $6.49 Million - $7.24 Million
-63,020 Reduced 83.54%
12,416 $1.32 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $7.38 Million - $9.47 Million
-84,427 Reduced 52.81%
75,436 $8.37 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $175,822 - $197,516
-2,080 Reduced 1.28%
159,863 $13.8 Million
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $9.62 Million - $10.9 Million
-115,247 Reduced 41.58%
161,943 $14.8 Million
Q1 2022

May 03, 2022

BUY
$73.51 - $82.4 $599,915 - $672,466
8,161 Added 3.03%
277,190 $22.7 Million
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $90,494 - $113,356
-1,252 Reduced 0.46%
269,029 $20.6 Million
Q3 2021

Nov 16, 2021

SELL
$71.68 - $78.83 $294,174 - $323,518
-4,104 Reduced 1.5%
270,281 $20.3 Million
Q2 2021

Aug 03, 2021

BUY
$70.31 - $77.77 $6.37 Million - $7.05 Million
90,615 Added 49.31%
274,385 $21.3 Million
Q1 2021

Apr 21, 2021

BUY
$68.86 - $81.11 $1.38 Million - $1.63 Million
20,062 Added 12.25%
183,770 $14.2 Million
Q4 2020

Jan 26, 2021

SELL
$71.77 - $79.65 $330,716 - $367,027
-4,608 Reduced 2.74%
163,708 $13.4 Million
Q3 2020

Nov 03, 2020

SELL
$73.18 - $82.95 $1.25 Million - $1.41 Million
-17,038 Reduced 9.19%
168,316 $14 Million
Q2 2020

Jul 27, 2020

SELL
$70.42 - $80.13 $636,455 - $724,214
-9,038 Reduced 4.65%
185,354 $14.3 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $96,940 - $134,364
-1,530 Reduced 0.78%
194,392 $15 Million
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $621,648 - $701,458
-8,013 Reduced 3.93%
195,922 $17.8 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $1.15 Million - $1.25 Million
15,125 Added 8.01%
203,935 $17.2 Million
Q3 2019

Nov 04, 2019

BUY
$76.08 - $82.93 $260,574 - $284,035
3,425 Added 1.85%
188,810 $15.9 Million
Q3 2019

Nov 04, 2019

SELL
$76.08 - $82.93 $1.58 Million - $1.72 Million
-20,740 Reduced 10.06%
185,385 $15.6 Million
Q2 2019

Aug 15, 2019

SELL
$69.84 - $81.59 $208,053 - $243,056
-2,979 Reduced 1.42%
206,125 $17.3 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $5.58 Million - $6.36 Million
-80,138 Reduced 27.71%
209,104 $17.4 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $475,012 - $551,244
-7,281 Reduced 2.46%
289,242 $22.1 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $419,002 - $492,721
-7,263 Reduced 2.39%
296,523 $21 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $148,169 - $174,083
-2,915 Reduced 0.95%
303,786 $18.4 Million
Q1 2018

May 10, 2018

BUY
$50.96 - $59.23 $255,411 - $296,860
5,012 Added 1.66%
306,701 $16.7 Million
Q4 2017

Feb 15, 2018

BUY
$51.62 - $61.64 $435,104 - $519,563
8,429 Added 2.87%
301,689 $17 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $568,160 - $611,350
-9,684 Reduced 3.2%
293,260 $18.8 Million
Q2 2017

Aug 15, 2017

BUY
N/A
302,944
302,944 $19.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Klcm Advisors, Inc. Portfolio

Follow Klcm Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.